MERTK and cancer: In addition to the regulation of PD-L1 expression in cancer cells, the expression of PD-L1 in monocytes and macrophages was downregulated in MERTK-deficient mice or in MERTK-wild-type mice which were treated with an MERTK inhibitor called MRX-2843 [139].